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Objective: Postischemic reperfusion of the lung triggers proinflammatory responses that stimulate injurious
neutrophil chemotaxis. We hypothesized that T lymphocytes are recruited and activated during reperfusion
and mediate subsequent neutrophil-induced lung ischemia–reperfusion injury.
Methods: An in vivo mouse model of lung ischemia–reperfusion injury was used. C57BL/6 mice were assigned
to either the sham group (left thoracotomy) or 7 study groups that underwent 1-hour left hilar occlusion followed
by 1 to 24 hours of reperfusion. After in vivo reperfusion, the lungs were perfused ex vivo with buffer whereby
pulmonary function was assessed. Lung vascular permeability, edema, neutrophil accumulation, and cytokine/
chemokine production (tumor necrosis factor a, interleukin 17, CCL3, and CXCL1) were assessed based on
Evans blue dye leak, wet/dry weight ratio, myeloperoxidase level, and enzyme-linked immunosorbent assay,
respectively.
Results: A preliminary study showed that 2 hours of reperfusion resulted in greater pulmonary dysfunction than
1 or 24 hours of reperfusion. The 2-hour reperfusion period was thus used for the remaining experiments.
Comparable and significant protection from ischemia–reperfusion injury–induced lung dysfunction and injury
occurred after antibody depletion of neutrophils or CD4þT cells but not CD8þT cells (P<.05 vs immunoglobulin
G control). Lung ischemia–reperfusion injury was proportional to the infiltration of neutrophils but not T cells.
Moreover, pulmonary neutrophil infiltration and the production of CXCL1 (KC) were significantly diminished by
CD4þT-cell depletion but not vice versa.
Conclusions: Both CD4þT lymphocytes and neutrophils accumulate during reperfusion and contribute sequen-
tially to lung ischemia–reperfusion injury. The data suggest that neutrophils mediate ischemia–reperfusion injury;
however, CD4þT cells play a critical role in stimulating chemokine production and neutrophil chemotaxis during
ischemia–reperfusion injury.T
XRespiratory failure remains the most common complication
in the perioperative period after lung transplantation. One of
the major causes of respiratory failure and complications
acutely observed after transplantation is ischemia–reperfu-
sion injury (IRI),1 which has been reported to be responsible
for up to 30% of patient mortality within 30 days.2 An in-
creasing body of evidence has shown that IRI is associated
with enhanced inflammatory responses during reperfusion.
Our previous animal experiments have shown that alveolar
macrophages and circulating leukocytes contribute impor-
tantly to lung IRI, with macrophages serving as triggers
and leukocytes (mainly neutrophils) serving as end-effec-
tors.3-6 Furthermore, we recently reported that alveolar
epithelial cells, especially type II cells, interact with alveolar
macrophages to initiate inflammatory responses during IRI.7
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phages and neutrophils remain to be defined.
There is growing evidence that T cells might also partici-
pate in the pathogenesis of lung IRI.8-10 T cells are found to
infiltrate the lung and are activated during reperfusion earlier
than neutrophils.10 Lymphocyte-deficient rats or mice have
decreased IRI.9,10 Cytokines and chemokines that stimulate
T-cell chemotaxis and activation, such as interleukin (IL) 8,
IL-12, IL-18, CCL5, and CCL2, are increased during lung
IRI.7,9,11-13 T cells are known to amplify inflammatory
responses through the secretion of lymphokines, including
interferon g (IFN-g), IL-2, IL-4, IL-17, and granulocyte–
macrophage colony-stimulating factor.9,14 These stimulate
the chemotaxis of neutrophils andmonocytes to sites of injury.
Whether T cells participate importantly in the inflamma-
tory cascade that results in lung IRI is unclear. In the current
study we used an in vivo mouse model of lung IRI to exam-
ine the role of T cells in lung IRI. Because neutrophils are
end-effectors of lung IRI, we also examined the effect of
lymphocyte depletion of neutrophil trafficking into the
lung. Monoclonal antibodies (mAbs) were used to render
mice deficient in neutrophils, CD4þT cells, or CD8þT cells.
MATERIALS AND METHODS
Animals
This study used a total of 74 (8- to 12-week-old) male C57BL/6 mice
(Jackson Laboratory, Bar Harbor, Me), which were assigned to 7 IRI studyardiovascular Surgery c Volume 137, Number 3 695
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XAbbreviations and Acronyms
BAL ¼ bronchoalveolar lavage
IFN-g ¼ interferon g
IgG ¼ immunoglobulin G
IL ¼ interleukin
IRI ¼ ischemia–reperfusion injury
LC ¼ lung compliance
mAb ¼ monoclonal antibody
MPO ¼ myeloperoxidase
TNF-a ¼ tumor necrosis factor a
groups and 1 sham group that underwent surgical intervention but not hilar
clamping. This study conformed to the ‘‘Guide for the care and use of lab-
oratory animals’’ published by the National Institute of Health (publication
no. 85-23, revised 1985) and was conducted under protocols approved by
the University of Virginia’s Institutional Animal Care and Use Committee.
In Vivo Depletion of Neutrophils
Rat anti-mouse Gr-1 mAb was used to deplete circulating neutrophils in
mice, as reported by others.15 Briefly, 10 mg of anti-Gr-1 mAb (eBioscience,
San Diego, Calif) was injected through the tail vein 24 hours before lung
ischemia. Perioperatively, blood (30–40 mL) was obtained by puncturing
the left external jugular vein, and leukocyte counts were performed with
a HemaVet Hematology System (CDC Technologies, Oxford, Conn).
In Vivo Depletion of CD4þ or CD8þT Lymphocytes
Depletion of CD4þor CD8þT cells was achieved by using selective an-
tibodies, as reported previously.16 Anti–CD4 mAb (GK1.5) or anti–CD8a
mAb (53-6.7, eBioscience) was injected intraperitoneally on 2 consecutive
days at a dose of 0.2 mg per mouse per day. Two days after the second
injection, these animals underwent lung ischemia.
In Vivo Model of Lung Ischemia and Reperfusion
Mice were anesthetized with inhalation of isoflurane, intubated with PE-
60 tubing, and connected to a pressure-controlled ventilator (Harvard Appa-
ratus Co, South Natick, Mass). Mechanical ventilation was performed with
room air as adjusted to a rate of 150 strokes/min, a stroke volume of 1.0 mL,
and a peak inspiratory pressure of less than 20 cm H2O. Heparin (20 U/kg)
was administered through external jugular injection. A left thoracotomywas
performed by cutting the left fourth rib, and the left hilum was exposed. A
6-0 Prolene suture (Ethicon, Inc, Somerville, NJ) was placed around the
hilum facilitated by a tip-curved (22-gauge) gavage needle. Both ends of
the suture were then threaded through a 5-mm-long PE-50 tubing. Occlu-
sion was achieved by pulling up on the suture and thus pushing the tube
against the hilum to initiate ischemia. A small surgical clip was applied to
the suture on top of the tube to maintain tension of the tube against the
hilum. The thoracotomy was then closed with sutures, and the mouse was
extubated, placed in a cage, and allowed to awaken during the 1-hour hilar
occlusion period. Five minutes before reperfusion, the mouse was reanes-
thetized and reintubated. Reperfusion was achieved by removing the clip
and the tube/suture. Again, the chest was closed with sutures. The mouse
was extubated and returned to a cage until pulmonary function testing.
The temperature was monitored during surgical intervention with an anal
probe and maintained between 36.5C and 37.5C. Sham animals received
only thoracotomy without hilar occlusion. To minimize pain and discom-
fort, an analgesic (buprenorphine, 0.2 mg/kg) was administered to all ani-
mals at the beginning of surgical intervention.696 The Journal of Thoracic and Cardiovascular SurMeasurement of Pulmonary Function
At the end of scheduled reperfusion, pulmonary function was evaluated
by using an isolated, buffer-perfused mouse lung system (Hugo Sachs Elek-
tronik, March-Huggstetten, Germany), as previously described by our lab-
oratory.6 Briefly, mice were anesthetized with ketamine and xylazine. A
tracheostomy was performed, and animals were ventilated with room air
at 100 strokes/min and a tidal volume of 7 mL/g body weight with a positive
end-expiratory pressure of 2 cm H2O. The animals were exsanguinated by
means of inferior caval transection. The pulmonary artery was cannulated
through the right ventricle, and the left ventricle was immediately tube
vented through a small incision at the apex of the heart. The lungs were
then perfused at a constant flow of 60 mL per gram of body weight per min-
ute with Krebs–Henseleit buffer containing 2% albumin, 0.1% glucose,
and 0.3% N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (335–340
mOsm/kg H2O). The perfusate buffer and isolated lungs were maintained
at 37C throughout the experiment by using a circulating water bath.
Once properly perfused and ventilated, the lungs were maintained on the
system for a 5-minute equilibration period before data were recorded for
an additional 10 minutes. Hemodynamic and pulmonary parameters were
recorded during this period by using the PULMODYN data acquisition sys-
tem (Hugo Sachs Elektronik).
Bronchoalveolar Lavage
After pulmonary function measurements, the left lungs were lavaged
with 0.4 mL of normal saline. A microclamp was used to occlude the right
hilum before lavage. The bronchoalveolar lavage (BAL) fluid was immedi-
ately centrifuged at 4C (500g for 5 minutes), and the supernatant was
stored at80C until further analysis.
Lung Wet/Dry Weight Ratio
In separate groups the left lung was harvested, weighed, and then placed
in a vacuum oven (at 58C) until a stable dry weight was achieved. The ratio
of lung wet weight to dry weight was then calculated.
Pulmonary Microvascular Permeability
IRI-induced microvascular permeability in the lungs was determined by
using the Evans blue dye extravasation technique.17 Evans blue (20 mg/kg;
Sigma–Aldrich, St Louis,Mo) was injected intravenously 30minutes before
death. The pulmonary vasculature was then perfused for 15 minutes by us-
ing the isolated, buffer-perfused lung system to remove intravascular dye.
Lungs were then homogenized in phosphate-buffered saline to extract the
Evans blue and centrifuged. The absorption of Evans blue was measured
in the supernatant at 620 nm and corrected for the presence of heme
pigments as follows:
A620 ðcorrectedÞ ¼ A620ð1:426 3 A740 þ 0:030Þ.
Immunohistochemistry
A standard immunohistochemistry protocol for paraformaldehyde-fixed
tissue was used, as detailed previously.16 Briefly, the left lung was har-
vested, cut into 4 short-axis slices, and immediately fixed in 1% paraformal-
dehyde in phosphate-buffered saline (pH 7.4) for paraffin embedding.
Immunostaining was performed with rat anti-mouse neutrophil antibody
(Serotec, Inc, Oxford, United Kingdom), anti-CD3 antibody (Santa Cruz
Biotechnology, Santa Cruz, Calif), or anti-Mac2 antibody (Accurate Chem-
ical & Scientific Corp, Westbury, NY). Three lung tissue slides (1 slide per
mouse) from each group were used for semiquantitative cell counts in pe-
ripheral lung tissue. These cell counts did not distinguish among cells in var-
ious components of the lung (eg, airspace, interstitial, or marginated) but
included all cells in peripheral (alveolar) lung tissue. On each slide, the
lung tissue was divided into 4 to 6 parallel zones, and 1 photo was taken
at each zone where the target cells were found in the highest numbers at
1003 magnification.gery c March 2009
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FIGURE 1. Complete blood cell counts in antibody-treated mice. A, Before hilar ligation, there was an 80% reduction in neutrophils in neutrophil-depleted
mice compared with IgG control mice, a 19% reduction in lymphocytes in CD8-depleted mice, and a 26% reduction of lymphocytes in CD4-depleted mice.
*P<.05 versus IgG control mice. B, Reperfusion caused a significant decrease in total circulating leukocytes and lymphocytes in all antibody-treated mice.
However, circulating neutrophils also increased after reperfusion, but this was significant only in IgG control mice. #P<.05 versus the corresponding group in
panel A. WBC, Total white blood cells.T
XMeasurement of Myeloperoxidase
Myeloperoxidase (MPO) was measured in BAL fluid by using a mouse
MPO enzyme-linked immunosorbent assay kit (Cell Sciences, Canton,
Mass).
Measurement of Cytokines/Chemokines
Cytokines/chemokines in BAL fluid were quantified by using the Bio-
plex Bead Array technique with a multiplex cytokine panel assay (Bio-
Rad Laboratories, Hercules, Calif), as previously done by our laboratory.7
The samples were analyzed as instructed with the Bioplex array reader,
which is a fluorescent-based flow cytometer using a bead-based multiplex
technology, each of which is conjugated with a reactant specific for a differ-
ent target molecule.
Statistical Analysis
All data are presented as the mean  standard error of the mean. Data
were compared with 1-way analysis of variance, followed by the Student’s
t test for unpaired data with the Bonferroni correction. Square roots of tissue
cell counts were compared by using 1-way analysis of variance.
RESULTS
Time Course of Reperfusion Injury After 1 Hour
of Hilar Ligation
To define the time point during reperfusion when lung in-
jury was most significant, we evaluated pulmonary function
after 1, 2, and 24 hours of reperfusion and after 1 hour of is-
chemia. At each time point, significant and roughly compa-
rable elevations in pulmonary artery pressure and airwayThe Journal of Thoracic and Cresistance occurred (data not shown). Lung compliance
(LC) was significantly worse after 2 and 24 hours of reper-
fusion versus that seen in sham mice (2.34  0.19 and
4.02  0.19 vs 5.61  0.36 mL/cm H2O, respectively;
P< .05). LC was not significantly reduced after 1 hour of
reperfusion (4.52  0.65 mL/cm H2O) but was significantly
worse at 2 hours of reperfusion compared with that seen at 1
and 24 hours (P<.05). Based on these data, 1 hour of ische-
mia and 2 hours of reperfusion were used for the remainder
of the study.
Changes in Circulating Leukocyte Numbers
Whole blood samples were collected from antibody-
treatedmice before ischemia and after 2 hours of reperfusion,
and blood cells were counted with a HemaVet Hematology
System (Figure 1). In neutrophil-depleted mice there was
a greater than 80% reduction in the number of neutrophils
(P< .05); however, there was also a significant reduction
in monocytes (80%) compared with that seen in immuno-
globulin G (IgG) isotype control mice (Figure 1, A). After re-
perfusion, the total number of circulating white blood cells
and lymphocytes was significantly reduced in both IgG con-
trol and neutrophil-depleted mice compared with that seen
before ischemia (Figure 1, B). Monocytes were further sig-
nificantly reduced in IgG control mice after reperfusion butardiovascular Surgery c Volume 137, Number 3 697
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XTABLE 1. Counts of leukocyte cell infiltration in peripheral lung tissue
Groups (n ¼ 3–5) Sham IgG control mice Neutrophil-depleted mice CD8þT cell–depleted mice CD4þT cell–depleted mice
Neutrophils 4.2  0.7 30.8  2.7* 6.4  0.9z 24.5  1.2* 17.5  1.7*y
CD3þT cells 6.4  0.5 10.3  0.9* 9.4  0.7* 6.8  0.5 2.7  0.4z
Macrophages 5.2  0.6 3.7  0.3 3.6  0.5 5.2  0.3 3.5  0.4
*P< .05 versus sham mice. yP< .05 versus IgG control and CD8-depleted mice. zP< .05 versus all groups.not in neutrophil-depleted mice. On the contrary, neutrophils
were significantly increased by 2-fold after reperfusion in
IgG control mice (compared with before ischemia) and
not significantly increased in neutrophil-depleted mice
(Figure 1, B).
In CD8- or CD4-depleted mice before ischemia, there
were no significant changes in the number of total white
blood cells, lymphocytes, neutrophils, or monocytes (Fig-
ure 1, A). Two hours after reperfusion (compared with before
ischemia), there were significant reductions in total white
blood cells (42%) and lymphocytes (70%) in CD8-depleted
mice, and values were 56% and 75% in CD4-depleted mice,
respectively (P< .05; Figure 1, B). Similar to what was ob-
served in IgG isotype control mice, neutrophils were in-
creased in CD8- and CD4-depleted mice after reperfusion,
but these levels were not significant (Figure 1, B). There
were no differences in the level of hemoglobin and platelets
among all antibody-treated mice before or after reperfusion
(data not shown).
Changes in Leukocyte Numbers and BAL MPO
Levels
In sham and antibody-treated mice leukocytes in periph-
eral (alveolar) lung tissue were semiquantitatively evaluated
in the left lung by means of immunohistochemistry. There
were no significant differences in macrophage numbers be-
tween antibody-treated (after IRI) and sham mice (Table 1
and Figure 2, B, bottom row). Both CD4þ and CD8þT cells
express CD3 antigen, and thus immunohistochemistry with
anti-CD3 antibody was used to assess combined CD4þ and
CD8þT cells. CD3þT cells were significantly increased after
IRI in IgG control and neutrophil-depleted mice compared
with those seen in sham mice (Table 1). CD3þT-cell counts
were not altered in CD8-depleted mice but were significantly
reduced in CD4-depleted mice (Table 1 and Figure 2, B,
middle row). Neutrophil numbers were significantly in-
creased in IgG control and CD8- and CD4-depleted mice
but not in neutrophil-depleted mice compared with those
seen in sham mice. However, neutrophil numbers were sig-
nificantly lower in CD4-depleted mice compared with those
seen in IgG control and CD8-depleted mice (Table 1 and
Figure 2, B, top row). MPO levels in BAL fluid, an indicator
of neutrophil infiltration into alveolar airspace, showed no
difference between sham, neutrophil-depleted, and CD4-de-
pleted mice but were significantly increased in IgG control
and CD8-depleted mice (Figure 2, A).698 The Journal of Thoracic and Cardiovascular SurPulmonary Function During Reperfusion
in Leukocyte-depleted Mice
As expected, pulmonary function was significantly im-
paired in lungs of IgG control mice after IRI compared
with that seen in sham mice (Figure 3). Airway resistance
was significantly increased, LC was significantly decreased,
and pulmonary artery pressure was significantly increased in
IgG control lungs. All parameters of pulmonary function
were partially but significantly improved in neutrophil-de-
pleted and CD4-depleted mice when compared with those
seen in IgG control mice (Figure 3). No protection was
observed in CD8-depleted mice.
Pulmonary Microvascular Permeability
Evans blue content in left lung tissue was measured to as-
sess pulmonary microvascular leak. As expected, there was
significantly higher Evans blue content after IRI (IgG con-
trol) versus that seen in sham mice (Figure 4, A). Evans
blue content was partially but significantly reduced in both
neutrophil-depleted and CD4-depleted mice compared with
that seen in IgG control andCD8-depletedmice (Figure 4,A).
FIGURE 2. Myeloperoxidase (MPO) levels and leukocyte subtype infiltra-
tion into peripheral lung tissue after reperfusion. A, Myeloperoxidase levels
in bronchoalveolar lavage fluid after reperfusion. *P< .05 versus sham
mice. B, Examples of immunohistochemical staining for neutrophils,
CD3þT cells, and macrophages in the study groups.gery c March 2009
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XLung Wet/Dry Weight Ratio
Lung wet/dry weight ratio, used as an indicator of edema,
was significantly increased in IgG control and CD8-depleted
mice versus that seen in sham mice. Importantly, wet/dry
weight ratio was significantly reduced in neutrophil- and
CD4-depleted mice (Figure 4, B).
Changes in BAL Fluid Cytokine/Chemokine
Expression
CCL3 (macrophage inflammatory protein 1), tumor ne-
crosis factor a (TNF-a), IL-17, and CXCL1 (KC) levels in
BAL fluid were significantly increased after IRI in IgG con-
trol mice and neutrophil- and CD8-depleted mice (Figure 5).
No significant induction of IFN-g or IL-12 was observed af-
ter IRI (data not shown). Neutrophil depletion significantly
reduced expression of IL-17. Depletion of CD4þT cells re-
sulted in significantly reduced CCL3, TNF-a, IL-17, and
CXCL1 levels versus those seen in IgG control mice. Deple-
tion of CD8þT cells did not significantly alter cytokine/che-
mokine expression versus that seen in IgG control mice.
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FIGURE 3. Effect of leukocyte subtype depletion on pulmonary function
after reperfusion. Airway resistance, lung compliance, and pulmonary artery
pressure were significantly improved in neutrophil-depleted and CD4þ T
cell–depleted mice. No protection was observed in CD8þ T cell–depleted
mice. *P< .05 versus sham mice. #P< .05 versus IgG control and CD8-
depleted mice.The Journal of Thoracic and CDISCUSSION
The current study used an in vivo mouse model to show
that significant lung IRI occurs as early as 1 hour after left
hilar ligation. Lung IRI was characterized by pulmonary
dysfunction, edema, microvascular leak, and leukocyte
infiltration. Lung IRI was significantly reduced in neutro-
phil- and CD4þ T cell–depleted mice but not in CD8þ T
cell–depleted mice. Circulating T cells were found to be
decreased after reperfusion, possibly because of vascular
margination or redistribution to the lung or other tissues.
Compared with sham mice, significant infiltration of CD3þ
T cells occurred in control and neutrophil- and CD8-de-
pleted mice but not in CD4-depleted mice. These results sug-
gest that lung IRI is directly related to the level of infiltrating
neutrophils but not T cells. The leukocyte counts performed
in this study did not distinguish among cells in various
components of the lung (eg, airspace, interstitial, or margin-
ated) and thus encompassed all peripheral (alveolar) lung
tissue. The results demonstrate that pulmonary neutrophil
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FIGURE 4. Microvascular permeability and pulmonary edema. A, Evans
blue content in lung tissue as an indicator of microvascular leak. In anti-
body-treated mice Evans blue content was more significantly increased in
IgG control and CD8-depleted mice than in neutrophil-depleted or CD4-
depleted mice. B, Lung wet/dry weight ratio, as an indicator of edema,
was significantly increased in IgG control and CD8-depleted mice but not
in neutrophil-depleted or CD4-depleted mice (Figure 5, B). *P<.05 versus
sham mice. #P< .05 versus IgG control and CD8-depleted mice.ardiovascular Surgery c Volume 137, Number 3 699
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Xinfiltration is dependent on CD4þT cells but not vice versa.
Cytokine/chemokine measurements revealed significantly
increased CCL3 (macrophage inflammatory protein 1),
TNF-a, IL-17, and CXCL1 (KC) production after reperfu-
sion, which were all significantly reduced by depletion of
CD4þ T cells. Taken together, these results indicate that
both neutrophils and CD4þ T cells contribute importantly
to acute lung IRI.
Mouse Model of Lung IRI
Inflammatory responses during lung IRI play a critical role
in early graft failure after lung transplantation.1,2,4,9,11,14,18
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FIGURE 5. Expression of cytokines/chemokines in bronchoalveolar
lavage fluid. CCL3 (macrophage inflammatory protein 1), tumor necrosis
factor a (TNF-a), interleukin 17 (IL-17), and CXCL1 (KC) levels were
all significantly increased in IgG control, neutrophil-depleted, and CD8-
depleted mice compared with those seen in sham mice. In CD4-depleted
mice there was no significant difference in CCL3, IL-17, and CXCL1 levels
compared with those seen in sham mice. CXCL1 levels in CD4-depleted
mice were significantly lower than in all other antibody-treated mice.
*P< .05 versus IgG control mice. #P< .05 versus CD8-depleted mice.
yP< .05 versus neutrophil-depleted mice.700 The Journal of Thoracic and Cardiovascular SurMost in vivo lung IRI models entail ligation of the left hilum
for 60 to 90minutes, followed by release of the ligature. Here
the mice are typically maintained on ventilation until some
point during reperfusion, and thus ventilator-induced lung
injury could have significantly contributed to thesemodels.19
The current study used a model with similar surgical inter-
vention; however, themechanical ventilation timewas short-
ened to less than 20 minutes to minimize the potential of
ventilator-induced lung injury. The absence of ventilator-
induced injury is reflected in the current study by the sham
mice, which display minimal lung injury and well-preserved
lung function compared with that seen in the IRI group. In
addition, lung function is relatively stable throughout 2 hours
of continuous ventilation and perfusion in sham mice (data
not shown), which would be expected to increase signifi-
cantly over time if ventilator-induced injury was a significant
component of this model.
Neutrophils Are End-effectors During Lung IRI
Studies have suggested that neutrophil accumulation
appears to be the prime cellular mediator of pulmonary
tissue destruction during IRI.1-4 Lung IRI induces all the
characteristics of an acute inflammatory response, such as
oxidative stress; activation of complement, macrophages,
and mast cells; elaboration of cytokines and chemokines;
release of chemotactic factors; expression of cell adhesion
molecules; neutrophil infiltration; and pulmonary
necrosis.1,3,4,6,10,20,21 Compelling evidence from a variety
of animal models and clinical studies indicates that neutro-
phils are the principle end-effectors of IRI.3,20,21 Significant
numbers of activated neutrophils accumulate in the lung af-
ter reperfusion, as determined by means of tissue immunos-
taining10 or increased activity of MPO,20 which is found
almost exclusively within neutrophils.22 Neutrophils are
generally believed to exacerbate tissue injury through the re-
lease of a variety of cytotoxic mediators, such as reactive ox-
ygen species and proteases.23,24 The current study is entirely
consistent with a critical role of neutrophils in causing lung
IRI. More than 80% of neutrophils were successfully de-
pleted with anti-Gr-1 antibody. However, in contrast to other
reports,15 a significant number of circulating monocytes
(80%) was also lost (Figure 1, A). The reduction in mono-
cytes might have been due to the use of intravenous injection
rather than intraperitoneal injection, as used previously.15
There was no significant reduction in lymphocytes. In the
neutrophil-depleted mice lung IRI was significantly reduced,
despite significant infiltration of CD3þT cells. Furthermore,
we found that protection from lung IRI correlated with a sig-
nificant reduction in neutrophil infiltration but not other sub-
types of leukocytes. These results demonstrate that activated
neutrophils are end-effectors, which directly cause lung IRI.
Although T lymphocytes might have some direct toxic ef-
fects on pulmonary tissues, they predominantly appear togery c March 2009
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Xamplify an inflammatory response that is chemotactic to
neutrophils.
CD4þT Lymphocytes Mediate Inflammatory
Responses During Reperfusion
An increasing body of evidence has shown that T cells
contribute importantly to lung IRI. T cells are activated
and infiltrate into the lung during reperfusion earlier than
neutrophils.10 Inhibition of T cells before reperfusion has
been shown to attenuate inflammation and decrease lung
IRI.20,25 These data are consistent with the current results,
which suggest that CD4þT cells, or a subset of these cells,
are activated during lung IRI.
To identify the role of CD4þT cells in lung IRI, we used
mice with antibody-induced depletion of either CD4þ or
CD8þT cells. After reperfusion, significantly less infiltration
of CD3þT cells was found in CD4- and CD8-depleted mice
than in IgG control and neutrophil-depleted mice (Table 1).
In sham mice there were higher numbers of peripheral lung
T cells and macrophages than neutrophils. There was no sig-
nificant change in the number of alveolar macrophages after
2 hours of reperfusion in all IRI groups; however, in the IgG
control group there was a further increase in the number of
infiltrating neutrophils and T cells, with the change of neu-
trophils being greater (Table 1). This increase in T-cell num-
bers might represent chemotaxis of circulating lymphocytes
because circulating lymphocytes were significantly reduced
during reperfusion. Although significant numbers of neutro-
phils are trapped (marginated or infiltrated) in the lungs,
circulating neutrophil numbers were increased after reperfu-
sion (statistical significance was reached only in IgG control
mice). The reason for the increase in circulating neutrophil
numbers is not clear but possibly reflects mobilization
from bone marrow in response to granulocyte–macrophage
colony-stimulating factor released by activated CD4þ T
cells. Compared with CD8þ T cell–depleted mice, CD4þ T
cell–depleted mice had significantly less infiltration of
CD3þ T cells and neutrophils with correspondingly less
lung IRI. However, neutrophil-depleted mice still exhibited
increased numbers of CD3þ T cells, as seen in IgG control
mice. Thus neutrophils have no effect on T-cell activation
during lung IRI. Taken together, these results demonstrate
that CD4þT cells and not CD8þT cells are activated during
lung IRI and play a critical role in amplifying an inflamma-
tory response, which culminates in the activation of neutro-
phils.
In lung IRI CD4þT cells could become activated through
either antigen-independent or antigen-dependent pathways.
Antigen-independent mechanisms for T-cell activation
have been described, which involve IL-12, TNF-a, CCL2,
CCL3, CCL5, and IFN-g–inducible protein 10.12,13,26 We
found that CCL3, TNF-a, IL-17, and CXCL1 were signifi-
cantly increased after IRI in all antibody-treated mice except
CD4-depleted mice. In CD4-depleted mice production ofThe Journal of Thoracic and CIL-17 and CXCL1 were significantly lower than seen in
other antibody-treated mice after IRI (except for IL-17 in
neutrophil-depleted mice), indicating that CD4þT-cell acti-
vation precedes CXCL1 induction. These results are consis-
tent with an antigen-independent pathway leading to CD4þ
T-cell activation during lung IRI. IL-17 activates alveolar
macrophages and epithelial type II cells to induce CXCL1,
which is a strong chemotactic mediator for neutrophil infil-
tration.7,27 Another possibility is that CD4þT cells are acti-
vated directly by factors produced during reperfusion to
release cytokines/chemokines that transactivate other leuko-
cytes and epithelial cells.
Clinical Effect
Identification of the initiatory signaling cascade through
CD4þ T cells and macrophages will likely lead to specific
pharmacologic interventional targets for the amelioration
of lung IRI. For example, recent studies by our group have
identified one such potential therapeutic agent to be the
A2A adenosine receptor, which resides on leukocytes, in-
cluding CD4þT cells and neutrophils. Here we have shown
that agonists that specifically activate A2A adenosine recep-
tors significantly reduce neutrophil infiltration and attenuate
lung IRI after transplantation.4,28 The possible protective
role of A2A adenosine receptors on CD4þT cells in the set-
ting of lung IRI and the underlying molecular mechanisms
are yet to be elucidated and are currently under investigation.
CONCLUSION
The current study suggests that sequential activation of
CD4þ T lymphocytes and neutrophils occurs during lung
IRI. CD4þT cells accumulate in the lung during reperfusion
but have little direct toxic effect. Instead, CD4þ T cells or-
chestrate the chemotaxis of circulating neutrophils to the
lung. Activated neutrophils are end-effectors, which carry
out damage-producing tasks, whereas CD4þ T cells play
a central role in mediating this injury process. The results
underscore the importance of CD4þT lymphocytes as medi-
ators of lung IRI.
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Discussion
Dr Craig Selzman (Chapel Hill, NC). That was a very nice pre-
sentation and a lot to take in in a short period of time. I am trying to
make some relevance out of this because it is almost like you make
the background for lung transplantation, but this is a hilar clamp
model. I waswondering if you could speculate on the role of temper-
ature andwhatwas the effect onmany of yourmarkers in thismodel.
Dr Yang. Thank you for your insightful comments. It is impor-
tant to maintain a lower temperature of the donor lung under clin-
ical situations. In this particular study our aim was to characterize
the inflammatory responses during lung IRI, and thus we purposely
maintained normal body temperature during occlusion and perfu-
sion. Thus we did not sort out the temperature factor in our model.
Dr Selzman. I guess what I was getting at is that normally the
temperature for a lung transplantation is a little bit lower.
Dr Yang. You are right.
Dr Selzman. Therefore I guess if you put a tape around a pulmo-
nary artery during a lobectomy and then you were going to reper-
fuse—therefore I would like you to try to speculate how you
might be able to figure that out. Also, did you administer any
kind of pulmonary protective agent before your experiment?
Dr Yang. It is feasible to lower the body temperature during re-
perfusion in our model, and it has been reported that hypothermia
ameliorates lung IRI. Although we did not address the temperature
factor in our model, I would speculate that a reduced temperature
would lower the inflammatory response during reperfusion. As
far as pretreatment is concerned, our laboratory has applied an
adenosine A2A receptor agonist, ATL313, to this model and found
that treatment before ischemia, as well as during reperfusion, is
quite protective.
Dr Selzman. Have you ever done this in your organ perfusion
model, your ex vivo model?
Dr Yang. You are talking about the isolated model previously?
Dr Selzman. It sounded like you had an isolated model.
Dr Yang. We do have an isolated, blood-perfused rabbit lung
model in our laboratory. In studies using this model, the isolated
lungs typically undergo cold ischemic storage followed by reperfu-
sion with blood at normal body temperature (37C) to simulate
a clinical lung transplantation. All groups were treated similarly
in terms of temperature. Therefore we could not determine from
these studies whether the temperature had been a factor of protec-
tion against IRI. However, even with lower ischemic temperature in
this model, reperfusion injury still existed, and intervention with
anti-inflammatory agents, such as ATL313, before reperfusion, is-
chemia, or both exerted significant protective effects. We did not
look into the effect of the temperature factor on lung IRI, but that
is an excellent point. It would be most interesting to design a study
to look into the role of lower temperature as part of the regimen to
prevent lung IRI after transplantation.gery c March 2009
